Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma.

Conditions:   Colorectal Neoplasms;   Microbiota;   Prognosis;   Metabolic Syndrome;   Sarcopenia Intervention:   Other: no intervention Sponsors:   University Hospital, Clermont-Ferrand;   M2iSH laboratory;   Benoit Chassaing Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials